Project cooperationUpdated on 19 January 2026
Translational Radiation Biodosimetry Diagnostics Laboratory
Professor at AZ Board of Regents on behalf of Arizona State University
Tempe, United States
About
The Biodosimetry Diagnostics Laboratory develops and validates molecular diagnostic tests to detect, quantify, and monitor human radiation exposure. The laboratory applies gene expression and proteomic signatures to create sensitive and specific biodosimetry tools capable of estimating radiation dose and biological impact.
Research spans discovery, assay development, and clinical validation, with an emphasis on both rapid point-of-care platforms and high-throughput laboratory-based diagnostics. These complementary approaches support timely triage in radiation emergencies as well as detailed exposure assessment in clinical, occupational, and research settings.
By integrating translational science with real-world use cases, the laboratory advances scalable, robust biodosimetry solutions that inform medical management, improve emergency preparedness, and support public health and national security responses to radiological and nuclear events.
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Similar opportunities
Project cooperation
Clinical Laboratory for Respiratory Pathogen Diagnostics and Validation
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Vel Murugan
Professor at AZ Board of Regents on behalf of Arizona State University
Tempe, United States
Project cooperation
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Hakim Ferria
European projects manager at INSA Lyon
Lyon, France
Project cooperation
HORIZON-HLTH-2026-01-ENVHLTH-01
- Partner seeks Consortium/Coordinator
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
EVANGELIA CHOLEVA
FUNDRAISING MANAGER at National Centre for Scientific Research Demokritos
ATHENS, Greece